[
  {
    "title": "智飞生物(300122.SZ)：治疗用卡介苗临床申请获受理",
    "href": "http://stock.jrj.com.cn/2023/01/06183537265003.shtml",
    "datetime": "2023-01-06 18:35:45",
    "code": "300122"
  },
  {
    "title": "A股异动 | 智飞生物一度涨约4% 智飞龙科马重组新冠病毒疫苗接种人群范围扩大至3岁以上",
    "href": "http://stock.jrj.com.cn/2022/12/26103137237335.shtml",
    "datetime": "2022-12-26 10:31:32",
    "code": "300122"
  },
  {
    "title": "多地“第四针”开打！智飞生物新冠疫苗接种范围扩大至3岁以上",
    "href": "http://stock.jrj.com.cn/2022/12/26000637236658.shtml",
    "datetime": "2022-12-26 00:06:04",
    "code": "300122"
  },
  {
    "title": "年度最佳雇主榜单出炉！智飞生物荣登全国TOP10",
    "href": "http://stock.jrj.com.cn/2022/12/24222637236111.shtml",
    "datetime": "2022-12-24 22:26:40",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：重组B群脑膜炎球菌疫苗(大肠杆菌)获批临床",
    "href": "http://stock.jrj.com.cn/2022/12/14191337212845.shtml",
    "datetime": "2022-12-14 19:13:11",
    "code": "300122"
  },
  {
    "title": "免疫原性和安全性良好 智飞生物子公司公布重组新冠疫苗最新研究",
    "href": "http://stock.jrj.com.cn/2022/11/25094137165807.shtml",
    "datetime": "2022-11-25 09:41:14",
    "code": "300122"
  },
  {
    "title": "智飞生物“贿赂销售”横跨十年已查赃款超87万 蒋仁生依赖代理生意暴富研发费长期偏低",
    "href": "http://stock.jrj.com.cn/2022/10/31104337098762.shtml",
    "datetime": "2022-10-31 10:43:20",
    "code": "300122"
  },
  {
    "title": "一纸意见稿，疫苗龙头巨震19%！HPV疫苗究竟怎么回事？",
    "href": "http://stock.jrj.com.cn/2022/10/28085037092464.shtml",
    "datetime": "2022-10-28 08:50:55",
    "code": "300122"
  },
  {
    "title": "冰火两重天！收入大增利润大降 智飞生物自主产品何时能挑大梁？",
    "href": "http://stock.jrj.com.cn/2022/10/28083537092705.shtml",
    "datetime": "2022-10-28 08:35:00",
    "code": "300122"
  },
  {
    "title": "智飞生物2022年前三季度净利56.07亿同比下滑33.28% 销售成本增加",
    "href": "http://stock.jrj.com.cn/2022/10/27213237091466.shtml",
    "datetime": "2022-10-27 21:32:41",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：第三季度净利18.78亿元，同比下降35.52%",
    "href": "http://stock.jrj.com.cn/2022/10/27162337089779.shtml",
    "datetime": "2022-10-27 16:23:34",
    "code": "300122"
  },
  {
    "title": "疫苗概念股走弱，智飞生物跌超12％",
    "href": "http://stock.jrj.com.cn/2022/10/27095737088442.shtml",
    "datetime": "2022-10-27 09:57:38",
    "code": "300122"
  },
  {
    "title": "时隔5年智飞生物再陷“行贿门” 市值蒸发超2000亿后还藏啥隐患",
    "href": "http://stock.jrj.com.cn/2022/10/20074937068738.shtml",
    "datetime": "2022-10-20 07:49:50",
    "code": "300122"
  },
  {
    "title": "智飞生物获得“一种多价肺炎球菌结合疫苗”发明专利",
    "href": "http://stock.jrj.com.cn/2022/10/19193237067921.shtml",
    "datetime": "2022-10-19 19:32:13",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：子公司近日获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/10/19173737067431.shtml",
    "datetime": "2022-10-19 17:37:00",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：重组B群脑膜炎球菌疫苗(大肠杆菌)临床申请获受理",
    "href": "http://stock.jrj.com.cn/2022/09/29180737031633.shtml",
    "datetime": "2022-09-29 18:07:37",
    "code": "300122"
  },
  {
    "title": "高光不再，智飞生物成也疫苗，败也疫苗！",
    "href": "http://stock.jrj.com.cn/2022/09/21170737011406.shtml",
    "datetime": "2022-09-21 17:07:35",
    "code": "300122"
  },
  {
    "title": "百家机构调研股曝光，疫苗龙头透露，奥密克戎疫苗研发有新进展！外资盯上机器人概念龙头（附股）",
    "href": "http://stock.jrj.com.cn/2022/09/17180937002283.shtml",
    "datetime": "2022-09-17 18:09:35",
    "code": "300122"
  },
  {
    "title": "智飞生物：上半年营收同比大增四成 持续加码研发在研管线稳步推进",
    "href": "http://stock.jrj.com.cn/2022/08/31170436958750.shtml",
    "datetime": "2022-08-31 17:04:33",
    "code": "300122"
  },
  {
    "title": "九价HPV疫苗年龄放开了！45岁也可接种，智飞生物早盘高开",
    "href": "http://stock.jrj.com.cn/2022/08/31123836957301.shtml",
    "datetime": "2022-08-31 12:38:30",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)半年度净利润37.29亿元 同比下降32.08%",
    "href": "http://stock.jrj.com.cn/2022/08/29202436948880.shtml",
    "datetime": "2022-08-29 20:24:17",
    "code": "300122"
  },
  {
    "title": "智飞生物：上半年实现净利润37.3亿元 同比下降32%",
    "href": "http://stock.jrj.com.cn/2022/08/29200036948762.shtml",
    "datetime": "2022-08-29 20:00:37",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：子公司取得发明专利证书、为一种针对呼吸道合胞病毒感染的组合疫苗",
    "href": "http://stock.jrj.com.cn/2022/08/17211836909601.shtml",
    "datetime": "2022-08-17 21:18:55",
    "code": "300122"
  },
  {
    "title": "智飞生物：子公司获得有关重组新冠蛋白的制备方法及其应用专利",
    "href": "http://stock.jrj.com.cn/2022/08/05154536873698.shtml",
    "datetime": "2022-08-05 15:45:55",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：智飞龙科马取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/08/05154236873742.shtml",
    "datetime": "2022-08-05 15:42:32",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：子公司取得一项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/07/11163636799121.shtml",
    "datetime": "2022-07-11 16:36:25",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)2021年度权益分派10派6元、股权登记日为7月14日",
    "href": "http://stock.jrj.com.cn/2022/07/07173636791394.shtml",
    "datetime": "2022-07-07 17:36:40",
    "code": "300122"
  },
  {
    "title": "智翔金泰募资金额超总资产3.9倍，与智飞生物关联交易一年翻70倍",
    "href": "http://stock.jrj.com.cn/ipo/2022/07/05082436782282.shtml",
    "datetime": "2022-07-05 08:24:00",
    "code": "300122"
  },
  {
    "title": "手握千亿龙头，69岁疫苗大佬再迎一个IPO！",
    "href": "http://stock.jrj.com.cn/2022/06/29082636766565.shtml",
    "datetime": "2022-06-29 08:26:00",
    "code": "300122"
  },
  {
    "title": "智飞掌门人“挂帅”智翔金泰IPO背后：隐现前君实、沃森高管身影",
    "href": "http://stock.jrj.com.cn/2022/06/22200636750824.shtml",
    "datetime": "2022-06-22 20:06:30",
    "code": "300122"
  },
  {
    "title": "智翔金泰拟登科创板，智飞生物蒋仁生“再战”资本市场",
    "href": "http://stock.jrj.com.cn/2022/06/21195936747462.shtml",
    "datetime": "2022-06-21 19:59:35",
    "code": "300122"
  },
  {
    "title": "智翔金泰拟登陆科创板：主营抗体药物生产 实控人为智飞生物董事长蒋仁生",
    "href": "http://stock.jrj.com.cn/2022/06/21103136745259.shtml",
    "datetime": "2022-06-21 10:31:39",
    "code": "300122"
  },
  {
    "title": "近一年股价跌去六成，还将被“踢出群”！智飞生物怎么了？",
    "href": "http://stock.jrj.com.cn/2022/06/16125736734046.shtml",
    "datetime": "2022-06-16 12:57:30",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)获得四价流感病毒裂解疫苗Ⅲ期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2022/06/16123536734003.shtml",
    "datetime": "2022-06-16 12:35:26",
    "code": "300122"
  },
  {
    "title": "重大调整！富时罗素宣布：中石油、格力电器、智飞生物被“剔除”，啥情况？这些公司新入列（名单）",
    "href": "http://stock.jrj.com.cn/2022/06/02065536698838.shtml",
    "datetime": "2022-06-02 06:55:16",
    "code": "300122"
  },
  {
    "title": "富时中国A50指数纳入海螺水泥、中信银行、通威股份 剔除智飞生物、格力电器、中国石油",
    "href": "http://stock.jrj.com.cn/2022/06/01175636697503.shtml",
    "datetime": "2022-06-01 17:56:56",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)取得2项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/05/19173136662723.shtml",
    "datetime": "2022-05-19 17:31:10",
    "code": "300122"
  },
  {
    "title": "智飞生物净利倍增股价却暴跌57% 大股东蒋仁生吴冠江疯狂套现210亿",
    "href": "http://stock.jrj.com.cn/2022/05/16104836650327.shtml",
    "datetime": "2022-05-16 10:48:40",
    "code": "300122"
  },
  {
    "title": "新冠疫苗研发又有突破！智飞生物登顶医药行业净利润新一哥",
    "href": "http://stock.jrj.com.cn/2022/05/12203036644141.shtml",
    "datetime": "2022-05-12 20:30:00",
    "code": "300122"
  },
  {
    "title": "A股异动 | 智飞生物(300122.SZ)涨约7% 第二代重组新冠疫苗预计7月进行临床申报",
    "href": "http://stock.jrj.com.cn/2022/05/11113436631769.shtml",
    "datetime": "2022-05-11 11:34:59",
    "code": "300122"
  },
  {
    "title": "持股市值近30亿，迎水投资一季度逆势加仓智飞生物",
    "href": "http://stock.jrj.com.cn/2022/05/06195336582626.shtml",
    "datetime": "2022-05-06 19:53:10",
    "code": "300122"
  },
  {
    "title": "智飞生物2022年第一季度净利19.23亿同比增长104.95% 本期销售持续增长",
    "href": "http://stock.jrj.com.cn/2022/05/04191136558794.shtml",
    "datetime": "2022-05-04 19:11:42",
    "code": "300122"
  },
  {
    "title": "智飞生物2021年净利102.09亿同比增长209.23% 董事长蒋仁生薪酬80万",
    "href": "http://stock.jrj.com.cn/2022/04/29051036498706.shtml",
    "datetime": "2022-04-29 05:10:48",
    "code": "300122"
  },
  {
    "title": "智飞生物：2021年净利同比增长209.23%至102.09亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28141436492165.shtml",
    "datetime": "2022-04-28 14:14:50",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：一季度净利升104.95%至19.23亿元",
    "href": "http://stock.jrj.com.cn/2022/04/27232436487477.shtml",
    "datetime": "2022-04-27 23:24:05",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)2021年度净利升209.23%至102.09亿元 拟10派6元",
    "href": "http://stock.jrj.com.cn/2022/04/27232136487479.shtml",
    "datetime": "2022-04-27 23:21:48",
    "code": "300122"
  },
  {
    "title": "智飞生物闪崩大跌18%！地产股拉升！京能置业、渝开发、中交地产涨停；业绩浪来袭，九安医疗连续三日涨停",
    "href": "http://stock.jrj.com.cn/2022/04/14131336333528.shtml",
    "datetime": "2022-04-14 13:13:40",
    "code": "300122"
  },
  {
    "title": "突发黑天鹅！两大千亿巨头突然崩了，热搜第一！新冠检测再掀涨停潮！国家重磅利好，白酒、餐饮旅游股大爆发",
    "href": "http://stock.jrj.com.cn/2022/04/14124136333449.shtml",
    "datetime": "2022-04-14 12:41:00",
    "code": "300122"
  },
  {
    "title": "A股午评：资金偏好权重股，上证50、茅指数涨超1%，智飞生物重挫18%",
    "href": "http://stock.jrj.com.cn/2022/04/14115236333129.shtml",
    "datetime": "2022-04-14 11:52:51",
    "code": "300122"
  },
  {
    "title": "WHO发声，智飞生物放量跳水盘中跌超18%，市值单日蒸发超340亿元",
    "href": "http://stock.jrj.com.cn/2022/04/14110536332693.shtml",
    "datetime": "2022-04-14 11:05:47",
    "code": "300122"
  },
  {
    "title": "疫苗股集体下挫 智飞生物大跌超18%",
    "href": "http://stock.jrj.com.cn/2022/04/14105936332380.shtml",
    "datetime": "2022-04-14 10:59:58",
    "code": "300122"
  },
  {
    "title": "智飞生物放量跳水跌超15%，总市值跌破2000亿元关口",
    "href": "http://stock.jrj.com.cn/2022/04/14104236332302.shtml",
    "datetime": "2022-04-14 10:42:34",
    "code": "300122"
  },
  {
    "title": "智飞生物2022年一季度预计净利17.83亿-19.7亿同比增长90%-110% 产品批签发数量增长",
    "href": "http://stock.jrj.com.cn/2022/03/31051036220910.shtml",
    "datetime": "2022-03-31 05:10:52",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)一季度净利润预增90%-110%",
    "href": "http://stock.jrj.com.cn/2022/03/30232136211088.shtml",
    "datetime": "2022-03-30 23:21:57",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：共同富裕之员工持股计划(2022年)完成购买2910万股",
    "href": "http://stock.jrj.com.cn/2022/03/18180834846248.shtml",
    "datetime": "2022-03-18 18:08:22",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：23价肺炎球菌多糖疫苗申请生产注册获得受理",
    "href": "http://stock.jrj.com.cn/2022/03/16180334835099.shtml",
    "datetime": "2022-03-16 18:03:18",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：控股股东3月14日大宗交易减持1.8%股份",
    "href": "http://stock.jrj.com.cn/2022/03/14182434825043.shtml",
    "datetime": "2022-03-14 18:24:13",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：智飞绿竹近日取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/03/09190834593733.shtml",
    "datetime": "2022-03-09 19:08:34",
    "code": "300122"
  },
  {
    "title": "【晚间公告全知道】智飞生物重组新冠蛋白疫苗获批附条件上市、顺丰控股拟10亿元至20亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/03/02220934513731.shtml",
    "datetime": "2022-03-02 22:09:51",
    "code": "300122"
  },
  {
    "title": "智飞生物：重组新型冠状病毒蛋白疫苗获批附条件上市",
    "href": "http://stock.jrj.com.cn/2022/03/02190434513209.shtml",
    "datetime": "2022-03-02 19:04:10",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：重组新冠蛋白疫苗获批附条件上市",
    "href": "http://stock.jrj.com.cn/2022/03/02190034513184.shtml",
    "datetime": "2022-03-02 19:00:54",
    "code": "300122"
  },
  {
    "title": "智飞生物：重组新冠蛋白疫苗获批附条件上市",
    "href": "http://stock.jrj.com.cn/2022/03/02185534513164.shtml",
    "datetime": "2022-03-02 18:55:55",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：共同富裕之员工持股计划(2022年)尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2022/02/21194134423648.shtml",
    "datetime": "2022-02-21 19:41:29",
    "code": "300122"
  },
  {
    "title": "智飞生物和康希诺AH股齐步拉升 入选中国新冠疫苗加强针“混打”方案",
    "href": "http://stock.jrj.com.cn/2022/02/18145534389780.shtml",
    "datetime": "2022-02-18 14:55:23",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：冻干重组结核疫苗进入Ⅱa期临床试验",
    "href": "http://stock.jrj.com.cn/2022/02/11175334324185.shtml",
    "datetime": "2022-02-11 17:53:03",
    "code": "300122"
  },
  {
    "title": "A股异动丨智飞生物(300122.SZ)4日连涨近20% 去年净利大增两倍破百亿",
    "href": "http://stock.jrj.com.cn/2022/02/10144134317965.shtml",
    "datetime": "2022-02-10 14:41:30",
    "code": "300122"
  },
  {
    "title": "智飞生物2021年净利101.97亿同比增长209% 自主产品与代理产品销售均提升",
    "href": "http://stock.jrj.com.cn/2022/02/08213134309972.shtml",
    "datetime": "2022-02-08 21:31:52",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)业绩快报：2021年度归母净利增208.88%至101.97亿元",
    "href": "http://stock.jrj.com.cn/2022/02/08194834308721.shtml",
    "datetime": "2022-02-08 19:48:52",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：拟推2022年员工持股计划 筹资上限16亿元",
    "href": "http://stock.jrj.com.cn/2022/01/28195134247001.shtml",
    "datetime": "2022-01-28 19:51:18",
    "code": "300122"
  },
  {
    "title": "智翔金泰生物进行IPO辅导 智飞生物、朗姿股份曾参与其融资",
    "href": "http://stock.jrj.com.cn/ipo/2022/01/26220834227421.shtml",
    "datetime": "2022-01-26 22:08:15",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)涨近4% 2021年净利预增200%-220%",
    "href": "http://stock.jrj.com.cn/2022/01/25100634208673.shtml",
    "datetime": "2022-01-25 10:06:04",
    "code": "300122"
  },
  {
    "title": "智飞生物2021年预计净利99.04亿-105.64亿同比增长200%-220% 代理产品销售提升",
    "href": "http://stock.jrj.com.cn/2022/01/24203034206250.shtml",
    "datetime": "2022-01-24 20:30:05",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：获得冻干人用狂犬病疫苗(MRC-5细胞)Ⅲ期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2022/01/24183534205647.shtml",
    "datetime": "2022-01-24 18:35:41",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)2021年度预盈99.04亿-105.64亿元 同比增长200%-220%",
    "href": "http://stock.jrj.com.cn/2022/01/24181834205538.shtml",
    "datetime": "2022-01-24 18:18:16",
    "code": "300122"
  },
  {
    "title": "智飞生物：2021年净利同比预增200%-220%",
    "href": "http://stock.jrj.com.cn/2022/01/24181534205519.shtml",
    "datetime": "2022-01-24 18:15:08",
    "code": "300122"
  },
  {
    "title": "智飞生物新冠疫苗在印尼获批序贯加强针 可使中和抗体水平提高约30倍",
    "href": "http://stock.jrj.com.cn/2022/01/11173634146656.shtml",
    "datetime": "2022-01-11 17:36:45",
    "code": "300122"
  },
  {
    "title": "智飞生物：重组新冠疫苗对奥密克戎变异株依然有效",
    "href": "http://stock.jrj.com.cn/2021/12/13145534008331.shtml",
    "datetime": "2021-12-13 14:55:43",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：双价痢疾结合疫苗进入III期临床试验",
    "href": "http://stock.jrj.com.cn/2021/12/10202533995962.shtml",
    "datetime": "2021-12-10 20:25:40",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：四价流脑结合疫苗进入III期临床试验",
    "href": "http://stock.jrj.com.cn/2021/12/10202433995961.shtml",
    "datetime": "2021-12-10 20:24:09",
    "code": "300122"
  },
  {
    "title": "一粒药让重庆首富“蒸发”百亿身家",
    "href": "http://stock.jrj.com.cn/2021/11/01062533794373.shtml",
    "datetime": "2021-11-01 06:25:45",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：第三季度净利升199.06%至29.13亿元",
    "href": "http://stock.jrj.com.cn/2021/10/28180633770608.shtml",
    "datetime": "2021-10-28 18:06:33",
    "code": "300122"
  },
  {
    "title": "智飞生物：第三季度净利29.13亿元 同比增长199.06%",
    "href": "http://stock.jrj.com.cn/2021/10/28173633770102.shtml",
    "datetime": "2021-10-28 17:36:36",
    "code": "300122"
  },
  {
    "title": "智飞生物跌8.08% 招商证券平安证券八月底唱多",
    "href": "http://stock.jrj.com.cn/2021/10/08180233658644.shtml",
    "datetime": "2021-10-08 18:02:00",
    "code": "300122"
  },
  {
    "title": "A股疫苗股补跌：智飞生物(300122.SZ)一度跌超9%",
    "href": "http://stock.jrj.com.cn/2021/10/08102133656230.shtml",
    "datetime": "2021-10-08 10:21:06",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：实控人蒋仁生质押365万股及解押950万股",
    "href": "http://stock.jrj.com.cn/2021/09/17221133453664.shtml",
    "datetime": "2021-09-17 22:11:00",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：实控人蒋仁生解押410万股",
    "href": "http://stock.jrj.com.cn/2021/09/10212333417125.shtml",
    "datetime": "2021-09-10 21:23:59",
    "code": "300122"
  },
  {
    "title": "智飞生物跌3.01% 招商证券平安证券上周一唱多",
    "href": "http://stock.jrj.com.cn/2021/09/08172133404798.shtml",
    "datetime": "2021-09-08 17:21:00",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)第二期员工持股计划终止",
    "href": "http://stock.jrj.com.cn/2021/09/05165233385870.shtml",
    "datetime": "2021-09-05 16:52:23",
    "code": "300122"
  },
  {
    "title": "智飞生物跌5.31% 招商证券平安证券周一唱多",
    "href": "http://stock.jrj.com.cn/2021/09/03180233381147.shtml",
    "datetime": "2021-09-03 18:02:00",
    "code": "300122"
  },
  {
    "title": "智飞生物跌超5%，科创创业ETF(588360)盘中跌超2%",
    "href": "http://stock.jrj.com.cn/2021/09/02141233373922.shtml",
    "datetime": "2021-09-02 14:12:06",
    "code": "300122"
  },
  {
    "title": "A股异动丨智飞生物(300122.SZ)大涨逾13% 中期净利增长264.94%至54.91亿",
    "href": "http://stock.jrj.com.cn/2021/08/30093733350099.shtml",
    "datetime": "2021-08-30 09:37:23",
    "code": "300122"
  },
  {
    "title": "智飞生物2021年半年度净利54.91亿元 同比净利增加264.94%",
    "href": "http://stock.jrj.com.cn/2021/08/29195933341397.shtml",
    "datetime": "2021-08-29 19:59:21",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)半年度净利润54.91亿元 同比增长264.94%",
    "href": "http://stock.jrj.com.cn/2021/08/29175833340909.shtml",
    "datetime": "2021-08-29 17:58:35",
    "code": "300122"
  },
  {
    "title": "智飞生物：上半年净利润54.91亿元 同比增265%",
    "href": "http://stock.jrj.com.cn/2021/08/29174733340874.shtml",
    "datetime": "2021-08-29 17:47:14",
    "code": "300122"
  },
  {
    "title": "新冠疫苗重大利好：智飞生物“重组蛋白”路径产品Ⅲ期临床即将收官 Delta变异株防护率77.54%",
    "href": "http://stock.jrj.com.cn/2021/08/29075733345957.shtml",
    "datetime": "2021-08-29 07:57:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：收到重组新型冠状病毒疫苗（CHO细胞）Ⅲ期临床试验关键性数据",
    "href": "http://stock.jrj.com.cn/2021/08/27180233334452.shtml",
    "datetime": "2021-08-27 18:02:29",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：智飞绿竹轮状病毒灭活疫苗启动Ⅰ期临床试验",
    "href": "http://stock.jrj.com.cn/2021/08/05174233207994.shtml",
    "datetime": "2021-08-05 17:42:15",
    "code": "300122"
  },
  {
    "title": "智飞生物股东吴冠江减持1596.79万股 套现约34.46亿 一季度公司净利9.38亿",
    "href": "http://stock.jrj.com.cn/2021/08/02213533190870.shtml",
    "datetime": "2021-08-02 21:35:03",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：吴冠江减持期届满 累计减持0.998%股份",
    "href": "http://stock.jrj.com.cn/2021/08/02180733189994.shtml",
    "datetime": "2021-08-02 18:07:23",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)拟捐赠3000万元现金物资驰援河南",
    "href": "http://stock.jrj.com.cn/2021/07/27115533157300.shtml",
    "datetime": "2021-07-27 11:55:00",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：实控人蒋仁生质押427万股",
    "href": "http://stock.jrj.com.cn/2021/07/02214633035764.shtml",
    "datetime": "2021-07-02 21:46:23",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：取得两项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/07/02214333035759.shtml",
    "datetime": "2021-07-02 21:43:37",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：实控人蒋仁生质押360万股",
    "href": "http://stock.jrj.com.cn/2021/06/21174132970376.shtml",
    "datetime": "2021-06-21 17:41:23",
    "code": "300122"
  },
  {
    "title": "智飞生物：皮内注射用卡介苗（BCG）是公司开发的全新工艺和配方的疫苗",
    "href": "http://stock.jrj.com.cn/2021/06/18202032956594.shtml",
    "datetime": "2021-06-18 20:20:16",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：注射用母牛分枝杆菌新增适应症获批",
    "href": "http://stock.jrj.com.cn/2021/06/16180532941539.shtml",
    "datetime": "2021-06-16 18:05:06",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：母牛分枝杆菌疫苗(结核感染人群用)药品批准证明文件处于待领取状态",
    "href": "http://stock.jrj.com.cn/2021/06/11173632912218.shtml",
    "datetime": "2021-06-11 17:36:33",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：实控人蒋仁生质押的807.2981万股延期购回",
    "href": "http://stock.jrj.com.cn/2021/06/08185532894925.shtml",
    "datetime": "2021-06-08 18:55:05",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司母牛分枝杆菌疫苗（结核感染人群用）目前处于上市审评阶段",
    "href": "http://stock.jrj.com.cn/2021/06/07070032885120.shtml",
    "datetime": "2021-06-07 07:00:42",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司现有在售代理产品5种四价HPV疫苗、九价HPV疫苗、五价轮状疫苗等",
    "href": "http://stock.jrj.com.cn/2021/06/07064132884920.shtml",
    "datetime": "2021-06-07 06:41:02",
    "code": "300122"
  },
  {
    "title": "A股头条：华为发布多款搭载鸿蒙新产品 富时中国A50指数将纳入金龙鱼、智飞生物",
    "href": "http://stock.jrj.com.cn/2021/06/03070632867404.shtml",
    "datetime": "2021-06-03 07:06:54",
    "code": "300122"
  },
  {
    "title": "富时中国A50指数将纳入金龙鱼、智飞生物",
    "href": "http://stock.jrj.com.cn/2021/06/02182432864500.shtml",
    "datetime": "2021-06-02 18:24:40",
    "code": "300122"
  },
  {
    "title": "盛通股份：公司包装印刷定位卡纸包装 客户包括中国生物、智飞生物、泰德制药、华润集团等",
    "href": "http://stock.jrj.com.cn/2021/05/26155332823261.shtml",
    "datetime": "2021-05-26 15:53:42",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：子公司获得一项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/05/19192932782914.shtml",
    "datetime": "2021-05-19 19:29:13",
    "code": "300122"
  },
  {
    "title": "康希诺、智飞生物领涨疫苗股 国内多点零星病例再现",
    "href": "http://stock.jrj.com.cn/2021/05/17101232767935.shtml",
    "datetime": "2021-05-17 10:12:10",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：实控人蒋仁生解押3250万股",
    "href": "http://stock.jrj.com.cn/2021/05/11183532736589.shtml",
    "datetime": "2021-05-11 18:35:19",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司应收账款增加主要是销售规模持续增加所致",
    "href": "http://stock.jrj.com.cn/2021/05/08170732716974.shtml",
    "datetime": "2021-05-08 17:07:12",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司自主产品已顺利出口印尼、巴基斯坦等国家",
    "href": "http://stock.jrj.com.cn/2021/05/08170332716968.shtml",
    "datetime": "2021-05-08 17:03:44",
    "code": "300122"
  },
  {
    "title": "智飞生物：实控人及其一致人减持公司股份超1%",
    "href": "http://stock.jrj.com.cn/2021/04/27101632460553.shtml",
    "datetime": "2021-04-27 10:16:21",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司母牛分枝杆菌疫苗（结核感染人群用）目前处于上市审评阶段",
    "href": "http://stock.jrj.com.cn/2021/04/26101632452294.shtml",
    "datetime": "2021-04-26 10:16:15",
    "code": "300122"
  },
  {
    "title": "智飞生物2020年年报及2021年一季报点评：业绩超市场预期，新冠疫苗业绩兑现在即",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/21074232413881.shtml",
    "datetime": "2021-04-21 07:42:32",
    "code": "300122"
  },
  {
    "title": "智飞生物2021年第一季度净利增长81.69% 销售规模增大",
    "href": "http://stock.jrj.com.cn/2021/04/20173432410756.shtml",
    "datetime": "2021-04-20 17:34:43",
    "code": "300122"
  },
  {
    "title": "智飞生物2020年净利增长39.51% 董事长蒋仁生薪酬71.68万",
    "href": "http://stock.jrj.com.cn/2021/04/20140332409289.shtml",
    "datetime": "2021-04-20 14:03:07",
    "code": "300122"
  },
  {
    "title": "智飞生物去年净利33亿销售费用12亿 一季度葛兰增持",
    "href": "http://stock.jrj.com.cn/2021/04/20110532408468.shtml",
    "datetime": "2021-04-20 11:05:37",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)一季度净利润升81.69%至9.38亿元",
    "href": "http://stock.jrj.com.cn/2021/04/19215232404522.shtml",
    "datetime": "2021-04-19 21:52:09",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)2020年度净利润升39.51%至33.01亿元 拟10派5元",
    "href": "http://stock.jrj.com.cn/2021/04/19215032404512.shtml",
    "datetime": "2021-04-19 21:50:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司重组新型冠状病毒疫苗（CHO细胞）已被纳入紧急使用",
    "href": "http://stock.jrj.com.cn/2021/04/15175732380612.shtml",
    "datetime": "2021-04-15 17:57:13",
    "code": "300122"
  },
  {
    "title": "疫苗接种加速度！10亿国人望接种，细数国内三大疫苗，3000亿“疫苗王”Q2或迎真正爆发点！",
    "href": "http://stock.jrj.com.cn/2021/04/08191232333550.shtml",
    "datetime": "2021-04-08 19:12:53",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司重组新型冠状病毒疫苗（CHO细胞）已被纳入紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/30215932250285.shtml",
    "datetime": "2021-03-30 21:59:49",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司母牛分枝杆菌疫苗（结核感染人群用）目前处于上市审评阶段",
    "href": "http://stock.jrj.com.cn/2021/03/25160532216016.shtml",
    "datetime": "2021-03-25 16:05:13",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司重组新型冠状病毒疫苗（CHO细胞）已被纳入紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/22181632195841.shtml",
    "datetime": "2021-03-22 18:16:35",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)涨超4% 重组新型冠状病毒疫苗(CHO细胞)获批紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/22144332193840.shtml",
    "datetime": "2021-03-22 14:43:49",
    "code": "300122"
  },
  {
    "title": "智飞生物跌4% 上月底中金公司西部证券中泰证券喊买",
    "href": "http://stock.jrj.com.cn/2021/03/19173832164949.shtml",
    "datetime": "2021-03-19 17:38:00",
    "code": "300122"
  },
  {
    "title": "A股异动 | 智飞生物(300122.SZ)涨超5% 重组新冠疫苗被纳入紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/18095532155616.shtml",
    "datetime": "2021-03-18 09:55:36",
    "code": "300122"
  },
  {
    "title": "智飞生物高开高走，涨超3%，旗下新冠疫苗被纳入紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/18093332155449.shtml",
    "datetime": "2021-03-18 09:33:50",
    "code": "300122"
  },
  {
    "title": "智飞生物重组新型冠状病毒疫苗获国家药监局同意紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/17192532152610.shtml",
    "datetime": "2021-03-17 19:25:57",
    "code": "300122"
  },
  {
    "title": "【公告抢先看】晚间重要公告：智飞生物重组新冠疫苗被纳入紧急使用、阳谷华泰一季度净利预增1748%―1953%",
    "href": "http://stock.jrj.com.cn/2021/03/17183032152332.shtml",
    "datetime": "2021-03-17 18:30:14",
    "code": "300122"
  },
  {
    "title": "智飞生物：合作研发的重组新冠疫苗获药监局论证同意紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/17171132151803.shtml",
    "datetime": "2021-03-17 17:11:43",
    "code": "300122"
  },
  {
    "title": "智飞生物：重组新冠疫苗被纳入紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/17165932151635.shtml",
    "datetime": "2021-03-17 16:59:10",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：重组新冠疫苗被纳入紧急使用",
    "href": "http://stock.jrj.com.cn/2021/03/17165832151633.shtml",
    "datetime": "2021-03-17 16:58:29",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：吴冠江及一致行动人持股降至4.999994%",
    "href": "http://stock.jrj.com.cn/2021/03/12202232122468.shtml",
    "datetime": "2021-03-12 20:22:07",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：吴冠江已通过集中竞价减持1480.82万股",
    "href": "http://stock.jrj.com.cn/2021/03/12202032122461.shtml",
    "datetime": "2021-03-12 20:20:02",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：组份百白破疫苗进入Ⅰ期临床试验",
    "href": "http://stock.jrj.com.cn/2021/03/09183032098920.shtml",
    "datetime": "2021-03-09 18:30:59",
    "code": "300122"
  },
  {
    "title": "智飞生物跌11% 上月底中金公司西部证券中泰证券喊买",
    "href": "http://stock.jrj.com.cn/2021/03/09174632098595.shtml",
    "datetime": "2021-03-09 17:46:00",
    "code": "300122"
  },
  {
    "title": "智飞生物跌8.89% 上周中金公司西部证券中泰证券喊买",
    "href": "http://stock.jrj.com.cn/2021/03/04180532072033.shtml",
    "datetime": "2021-03-04 18:05:00",
    "code": "300122"
  },
  {
    "title": "一年净赚33亿却难有话语权，HPV疫苗或纳入免疫规划，智飞生物难阻毛利率、增速双双下滑",
    "href": "http://stock.jrj.com.cn/2021/02/26110332031780.shtml",
    "datetime": "2021-02-26 11:03:05",
    "code": "300122"
  },
  {
    "title": "智飞生物跌7.1% 近3日中金公司西部证券中泰证券喊买",
    "href": "http://stock.jrj.com.cn/2021/02/24180632019746.shtml",
    "datetime": "2021-02-24 18:06:00",
    "code": "300122"
  },
  {
    "title": "3日重挫近20%，智飞生物跌出机会了吗？",
    "href": "http://stock.jrj.com.cn/2021/02/22203932007794.shtml",
    "datetime": "2021-02-22 20:39:20",
    "code": "300122"
  },
  {
    "title": "持续专注疫苗及生物品研发，智飞生物去年营利齐增",
    "href": "http://stock.jrj.com.cn/2021/02/22101132004280.shtml",
    "datetime": "2021-02-22 10:11:37",
    "code": "300122"
  },
  {
    "title": "智飞生物2020年度净利33亿增长39.47% 疫苗产品销售稳定增长",
    "href": "http://stock.jrj.com.cn/2021/02/21192731999707.shtml",
    "datetime": "2021-02-21 19:27:09",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)业绩快报：2020年度净利润升39.47%至33亿元",
    "href": "http://stock.jrj.com.cn/2021/02/21165931999299.shtml",
    "datetime": "2021-02-21 16:59:38",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司重组新型冠状病毒疫苗（CHO细胞）项目相关信息请以公司信息披露为准",
    "href": "http://stock.jrj.com.cn/2021/02/20180031997912.shtml",
    "datetime": "2021-02-20 18:00:27",
    "code": "300122"
  },
  {
    "title": "智飞生物跌10.6% 尚信健投招商基金为前十大流通股东",
    "href": "http://stock.jrj.com.cn/2021/02/18181631987728.shtml",
    "datetime": "2021-02-18 18:16:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：mRNA技术平台具有其独特的优越性 也是未来疫苗研发的主要方向之一",
    "href": "http://stock.jrj.com.cn/2021/02/10152131883363.shtml",
    "datetime": "2021-02-10 15:21:50",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：持股5%以上股东吴冠江减持1.44%股份",
    "href": "http://stock.jrj.com.cn/2021/02/09185431878650.shtml",
    "datetime": "2021-02-09 18:54:39",
    "code": "300122"
  },
  {
    "title": "首次突破200元！智飞生物(300122.SZ)连涨3日再创上市新高",
    "href": "http://stock.jrj.com.cn/2021/02/05115731853947.shtml",
    "datetime": "2021-02-05 11:57:12",
    "code": "300122"
  },
  {
    "title": "疫苗板块整体走高 智飞生物涨幅居前",
    "href": "http://stock.jrj.com.cn/2021/02/01154131830014.shtml",
    "datetime": "2021-02-01 15:41:36",
    "code": "300122"
  },
  {
    "title": "[智飞生物]喜报:公司董事长蒋仁生荣获“全国抗击新冠肺炎疫情民营经济先进个人”",
    "href": "http://stock.jrj.com.cn/2021/01/23000031827103.shtml",
    "datetime": "2021-01-23 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：股东吴冠江及一直行动人减持公司股份达5%，拟继续减持不超过1.85%",
    "href": "http://stock.jrj.com.cn/2021/01/11104631668798.shtml",
    "datetime": "2021-01-11 10:46:05",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：股东吴冠江累计减持5%股份",
    "href": "http://stock.jrj.com.cn/2021/01/08203931657469.shtml",
    "datetime": "2021-01-08 20:39:29",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：股东吴冠江拟减持不超1.85%股份",
    "href": "http://stock.jrj.com.cn/2021/01/08203831657461.shtml",
    "datetime": "2021-01-08 20:38:11",
    "code": "300122"
  },
  {
    "title": "智飞生物：股东吴冠江及一致行动人已减持公司股份达到5%",
    "href": "http://stock.jrj.com.cn/2021/01/08203431657435.shtml",
    "datetime": "2021-01-08 20:34:20",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：15价肺炎球菌结合疫苗进入Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2020/12/29194631597084.shtml",
    "datetime": "2020-12-29 19:46:15",
    "code": "300122"
  },
  {
    "title": "西藏药业“豪赌”俄罗斯新冠疫苗 智飞生物身影闪现其中",
    "href": "http://stock.jrj.com.cn/2020/12/25073131566547.shtml",
    "datetime": "2020-12-25 07:31:56",
    "code": "300122"
  },
  {
    "title": "智飞生物续签默沙东独家代理 两年半内最高采购346亿元",
    "href": "http://stock.jrj.com.cn/2020/12/24045931556925.shtml",
    "datetime": "2020-12-24 04:59:56",
    "code": "300122"
  },
  {
    "title": "[智飞生物]声 明",
    "href": "http://stock.jrj.com.cn/2020/12/24000031562690.shtml",
    "datetime": "2020-12-24 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：与默沙东签署供应、经销与共同推广协议",
    "href": "http://stock.jrj.com.cn/2020/12/23081431550051.shtml",
    "datetime": "2020-12-23 08:14:54",
    "code": "300122"
  },
  {
    "title": "[智飞生物]产品批签发信息(2020年第二十九期)",
    "href": "http://stock.jrj.com.cn/2020/12/22000031544892.shtml",
    "datetime": "2020-12-22 00:00:00",
    "code": "300122"
  },
  {
    "title": "[智飞生物]我司全资子公司安徽智飞龙科马与上海市公共卫生临床中心合作签约仪式圆满举行",
    "href": "http://stock.jrj.com.cn/2020/12/18000031535804.shtml",
    "datetime": "2020-12-18 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物3500万入股深信生物成三股东 涉足mRNA技术平台完善疫苗产业布局",
    "href": "http://stock.jrj.com.cn/2020/12/09080831446132.shtml",
    "datetime": "2020-12-09 08:08:46",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)：实控人蒋仁生解除质押1480万股",
    "href": "http://stock.jrj.com.cn/2020/12/08173031441234.shtml",
    "datetime": "2020-12-08 17:30:14",
    "code": "300122"
  },
  {
    "title": "智飞生物认购深信生物股权 布局mRNA疫苗研发平台",
    "href": "http://stock.jrj.com.cn/2020/12/08040831434864.shtml",
    "datetime": "2020-12-08 04:08:48",
    "code": "300122"
  },
  {
    "title": "智飞生物(300122.SZ)拟3500万元认购深信生物10.189%股权",
    "href": "http://stock.jrj.com.cn/2020/12/07160431430517.shtml",
    "datetime": "2020-12-07 16:04:07",
    "code": "300122"
  },
  {
    "title": "智飞生物：我司装疫苗的玻璃瓶来自国内外知名企业",
    "href": "http://stock.jrj.com.cn/2020/12/03180731401453.shtml",
    "datetime": "2020-12-03 18:07:44",
    "code": "300122"
  },
  {
    "title": "[智飞生物]热烈祝贺我司董事长蒋仁生荣获首届“重庆市杰出英才奖”",
    "href": "http://stock.jrj.com.cn/2020/11/21000031336157.shtml",
    "datetime": "2020-11-21 00:00:00",
    "code": "300122"
  },
  {
    "title": "[智飞生物]金牛奖揭榜!智飞生物荣获最具投资价值奖、金牛董秘奖",
    "href": "http://stock.jrj.com.cn/2020/11/20000031336151.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "300122"
  },
  {
    "title": "A股异动丨智飞生物(300122.SZ)涨近4% 全资子公司的新冠疫苗进入三期临床试验",
    "href": "http://stock.jrj.com.cn/2020/11/16104831290662.shtml",
    "datetime": "2020-11-16 10:48:38",
    "code": "300122"
  },
  {
    "title": "慢病互联网复诊费将纳入医保支付范围 智飞生物新冠疫苗达到Ⅲ期临床试验标准 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/10/30181331176254.shtml",
    "datetime": "2020-10-30 18:13:04",
    "code": "300122"
  },
  {
    "title": "智飞生物：已完成的I、II期临床试验 获准开展第三期临床试验",
    "href": "http://stock.jrj.com.cn/2020/10/29205431159408.shtml",
    "datetime": "2020-10-29 20:54:53",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司半年报披露应收账款增长变动的原因主要是本期销售持续增加所致",
    "href": "http://stock.jrj.com.cn/2020/10/21083331097945.shtml",
    "datetime": "2020-10-21 08:33:42",
    "code": "300122"
  },
  {
    "title": "智飞生物董事长蒋仁生获评“重庆市抗击新冠肺炎疫情先进个人”",
    "href": "http://stock.jrj.com.cn/2020/10/20150331091961.shtml",
    "datetime": "2020-10-20 15:03:54",
    "code": "300122"
  },
  {
    "title": "智飞生物：前三季度营收及归母净利已超2019年全年 经营性现金流同比增长逾300%",
    "href": "http://stock.jrj.com.cn/2020/10/19133531082917.shtml",
    "datetime": "2020-10-19 13:35:48",
    "code": "300122"
  },
  {
    "title": "[智飞生物]武汉国家生物产业基地建设管理办公室钱德平一行 莅临我司调研指导",
    "href": "http://stock.jrj.com.cn/2020/10/16000031083869.shtml",
    "datetime": "2020-10-16 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物2020年前三季度净利24.79亿增长40.59% 本期销售代理进口产品增加",
    "href": "http://stock.jrj.com.cn/2020/10/15213831062451.shtml",
    "datetime": "2020-10-15 21:38:41",
    "code": "300122"
  },
  {
    "title": "智飞生物新冠疫苗生产线建成 董事长已率先注射",
    "href": "http://stock.jrj.com.cn/2020/10/10021531013386.shtml",
    "datetime": "2020-10-10 02:15:29",
    "code": "300122"
  },
  {
    "title": "智飞生物：全资子公司已具备重组新型冠状病毒疫苗（CHO细胞）的生产条件和资格",
    "href": "http://stock.jrj.com.cn/2020/09/29204330861473.shtml",
    "datetime": "2020-09-29 20:43:33",
    "code": "300122"
  },
  {
    "title": "[智飞生物]热烈祝贺我司首次入围2020中国制造业民营企业500强",
    "href": "http://stock.jrj.com.cn/2020/09/11000030740708.shtml",
    "datetime": "2020-09-11 00:00:00",
    "code": "300122"
  },
  {
    "title": "年内北上资金合计净买入超1000亿 智飞生物等10只白马股股价翻番",
    "href": "http://stock.jrj.com.cn/2020/09/07210430695416.shtml",
    "datetime": "2020-09-07 21:04:20",
    "code": "300122"
  },
  {
    "title": "业绩增长而销售毛利率持续下滑 疫苗概念股智飞生物真这么牛？",
    "href": "http://stock.jrj.com.cn/2020/08/27072030600962.shtml",
    "datetime": "2020-08-27 07:20:14",
    "code": "300122"
  },
  {
    "title": "[互动]智飞生物：新冠病毒疫苗正处于Ⅰ、Ⅱ期临床试验过程中",
    "href": "http://stock.jrj.com.cn/2020/08/20103630547323.shtml",
    "datetime": "2020-08-20 10:36:42",
    "code": "300122"
  },
  {
    "title": "智飞生物自研和代理疫苗销售双增 上半年盈利15亿投入1.4亿研发",
    "href": "http://stock.jrj.com.cn/2020/08/07081230447611.shtml",
    "datetime": "2020-08-07 08:12:00",
    "code": "300122"
  },
  {
    "title": "国家队调仓路线图抢先看：重仓疫苗龙头 养老金盯上9股",
    "href": "http://stock.jrj.com.cn/2020/08/05194230434827.shtml",
    "datetime": "2020-08-05 19:42:30",
    "code": "300122"
  },
  {
    "title": "智飞生物半年报点评：二季度业绩略超预期 新冠疫苗研发处于国内第一梯队",
    "href": "http://stock.jrj.com.cn/2020/08/05113930430805.shtml",
    "datetime": "2020-08-05 11:39:19",
    "code": "300122"
  },
  {
    "title": "卫健委、中医药管理局发文加强无烟医疗卫生机构建设 智飞生物上半年净利润增长超三成 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/04183830425276.shtml",
    "datetime": "2020-08-04 18:38:06",
    "code": "300122"
  },
  {
    "title": "智飞生物：上半年归母净利同比增长超30% 在研产品储备丰富",
    "href": "http://stock.jrj.com.cn/2020/08/04152030423615.shtml",
    "datetime": "2020-08-04 15:20:24",
    "code": "300122"
  },
  {
    "title": "自研产品和代理疫苗销售齐升 智飞生物上半年净利增超三成",
    "href": "http://stock.jrj.com.cn/2020/08/04070030418828.shtml",
    "datetime": "2020-08-04 07:00:15",
    "code": "300122"
  },
  {
    "title": "智飞生物上半年净利润增超三成",
    "href": "http://stock.jrj.com.cn/2020/08/03223830415805.shtml",
    "datetime": "2020-08-03 22:38:01",
    "code": "300122"
  },
  {
    "title": "智飞生物：上半年实现净利润15.05亿元 同比增长31.18%",
    "href": "http://stock.jrj.com.cn/2020/08/03203330415199.shtml",
    "datetime": "2020-08-03 20:33:00",
    "code": "300122"
  },
  {
    "title": "智飞生物2020年上半年净利15.05亿增长31.18% 稳步推动复工复产",
    "href": "http://stock.jrj.com.cn/2020/08/03202930415139.shtml",
    "datetime": "2020-08-03 20:29:08",
    "code": "300122"
  },
  {
    "title": "智飞生物上半年净利润同比增长31.18% 年内累涨282%",
    "href": "http://stock.jrj.com.cn/2020/08/03175930414303.shtml",
    "datetime": "2020-08-03 17:59:06",
    "code": "300122"
  },
  {
    "title": "智飞生物半年报：上半年净利润同比增长31%",
    "href": "http://stock.jrj.com.cn/2020/08/03175330414289.shtml",
    "datetime": "2020-08-03 17:53:25",
    "code": "300122"
  },
  {
    "title": "一个月85%涨幅的智飞生物，还有空间吗？",
    "href": "http://stock.jrj.com.cn/2020/08/03164530413793.shtml",
    "datetime": "2020-08-03 16:45:55",
    "code": "300122"
  },
  {
    "title": "生物疫苗概念再度活跃 智飞生物复星医药再创新高",
    "href": "http://stock.jrj.com.cn/2020/07/30095730382812.shtml",
    "datetime": "2020-07-30 09:57:00",
    "code": "300122"
  },
  {
    "title": "生物疫苗板块早盘跳水 冠昊生物跌停万泰生物、智飞生物等跌超6％",
    "href": "http://stock.jrj.com.cn/2020/07/28100030361183.shtml",
    "datetime": "2020-07-28 10:00:37",
    "code": "300122"
  },
  {
    "title": "智飞生物跌超6%！市值现为2389亿元 公告称股东减持比例达1%",
    "href": "http://stock.jrj.com.cn/2020/07/24140930332365.shtml",
    "datetime": "2020-07-24 14:09:04",
    "code": "300122"
  },
  {
    "title": "智飞生物：与中科院合作研发的重组新型冠状病毒疫苗正处于临床试验过程",
    "href": "http://stock.jrj.com.cn/2020/07/23202730325998.shtml",
    "datetime": "2020-07-23 20:27:43",
    "code": "300122"
  },
  {
    "title": "【龙虎榜】智飞生物7月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/23180030325189.shtml",
    "datetime": "2020-07-23 18:00:55",
    "code": "300122"
  },
  {
    "title": "[智飞生物]热烈祝贺我司全资子公司智飞龙科马副总经理杨世龙荣获安徽省五一劳动奖章",
    "href": "http://stock.jrj.com.cn/2020/07/23000030327752.shtml",
    "datetime": "2020-07-23 00:00:00",
    "code": "300122"
  },
  {
    "title": "【龙虎榜】智飞生物7月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/21180130305971.shtml",
    "datetime": "2020-07-21 18:01:41",
    "code": "300122"
  },
  {
    "title": "【龙虎榜】智飞生物7月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/14180330240110.shtml",
    "datetime": "2020-07-14 18:03:10",
    "code": "300122"
  },
  {
    "title": "智飞生物：重组新型冠状病毒疫苗启动Ⅱ期临床试验",
    "href": "http://stock.jrj.com.cn/2020/07/10123130203285.shtml",
    "datetime": "2020-07-10 12:31:00",
    "code": "300122"
  },
  {
    "title": "[智飞生物]智飞生物重组新型冠状病毒疫苗启动Ⅱ期临床试验",
    "href": "http://stock.jrj.com.cn/2020/07/10000030204118.shtml",
    "datetime": "2020-07-10 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物突围进化：产品为先 商业化与资本价值加速 | 聚焦国内医药生物产业重要公司",
    "href": "http://stock.jrj.com.cn/2020/07/07090830162582.shtml",
    "datetime": "2020-07-07 09:08:33",
    "code": "300122"
  },
  {
    "title": "智飞生物：合作研发的重组新型冠状病毒疫苗（CHO细胞）目前正在开展Ⅰ期临床试验",
    "href": "http://stock.jrj.com.cn/2020/07/01092330107643.shtml",
    "datetime": "2020-07-01 09:23:20",
    "code": "300122"
  },
  {
    "title": "智飞生物重组亚单位疫苗获批临床 北京将“应检尽检”人群纳入医保 | 医资周报",
    "href": "http://stock.jrj.com.cn/2020/06/28173930070065.shtml",
    "datetime": "2020-06-28 17:39:17",
    "code": "300122"
  },
  {
    "title": "又一新的技术路径 智飞生物子公司新冠疫苗获临床试验批件",
    "href": "http://stock.jrj.com.cn/2020/06/23202530001469.shtml",
    "datetime": "2020-06-23 20:25:46",
    "code": "300122"
  },
  {
    "title": "北京强调加快推进核酸检测 智飞生物重组新冠疫苗获得临床试验批件 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/06/23180130000429.shtml",
    "datetime": "2020-06-23 18:01:26",
    "code": "300122"
  },
  {
    "title": "智飞生物新冠疫苗获得临床试验批件 股价冲破百元大关",
    "href": "http://stock.jrj.com.cn/2020/06/23135529998454.shtml",
    "datetime": "2020-06-23 13:55:32",
    "code": "300122"
  },
  {
    "title": "智飞生物午后直线拉升触及涨停",
    "href": "http://stock.jrj.com.cn/2020/06/23130529998106.shtml",
    "datetime": "2020-06-23 13:05:59",
    "code": "300122"
  },
  {
    "title": "快讯：智飞生物急速拉升8.68% 主力资金净流出8097.72万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/23130229998091.shtml",
    "datetime": "2020-06-23 13:02:21",
    "code": "300122"
  },
  {
    "title": "午间公告集锦：智飞生物新型冠状病毒疫苗获得临床试验批件",
    "href": "http://stock.jrj.com.cn/2020/06/23121829997734.shtml",
    "datetime": "2020-06-23 12:18:17",
    "code": "300122"
  },
  {
    "title": "智飞生物：新型冠状病毒疫苗获得临床试验批件",
    "href": "http://stock.jrj.com.cn/2020/06/23121329997712.shtml",
    "datetime": "2020-06-23 12:13:52",
    "code": "300122"
  },
  {
    "title": "[智飞生物]智飞生物重组新型冠状病毒疫苗获批临床试验",
    "href": "http://stock.jrj.com.cn/2020/06/23000030112391.shtml",
    "datetime": "2020-06-23 00:00:00",
    "code": "300122"
  },
  {
    "title": "[智飞生物]热烈祝贺我司全资子公司智飞龙科马荣获合肥高新区“防控保供奖、投资贡献奖”等五项大奖",
    "href": "http://stock.jrj.com.cn/2020/06/01000030112390.shtml",
    "datetime": "2020-06-01 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物扣非净利三年增87倍 蒋仁生财富一年半涨371亿",
    "href": "http://stock.jrj.com.cn/2020/05/22080729737446.shtml",
    "datetime": "2020-05-22 08:07:20",
    "code": "300122"
  },
  {
    "title": "智飞生物独立董事袁林辞职 2019年薪酬为15万元",
    "href": "http://stock.jrj.com.cn/2020/05/18223429705420.shtml",
    "datetime": "2020-05-18 22:34:04",
    "code": "300122"
  },
  {
    "title": "智飞生物控股股东通过大宗交易向战投转让股份达到1%",
    "href": "http://stock.jrj.com.cn/2020/05/12213629653183.shtml",
    "datetime": "2020-05-12 21:36:48",
    "code": "300122"
  },
  {
    "title": "智飞生物：控股股东通过大宗交易向战投转让股份达到1%",
    "href": "http://stock.jrj.com.cn/2020/05/12181429652059.shtml",
    "datetime": "2020-05-12 18:14:48",
    "code": "300122"
  },
  {
    "title": "智飞生物结核防治1类新药获批上市 以岭药业澄清：连花清瘟安全性良好 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/05/11183429642538.shtml",
    "datetime": "2020-05-11 18:34:41",
    "code": "300122"
  },
  {
    "title": "结核病新药矩阵获突破 智飞生物打开成长空间",
    "href": "http://stock.jrj.com.cn/2020/05/11071229636268.shtml",
    "datetime": "2020-05-11 07:12:00",
    "code": "300122"
  },
  {
    "title": "智飞生物逾十年研发新品宜卡上市 系全球首款结核病诊断生物制品",
    "href": "http://stock.jrj.com.cn/2020/05/10211629628920.shtml",
    "datetime": "2020-05-10 21:16:00",
    "code": "300122"
  },
  {
    "title": "智飞生物一类新药宜卡上市 全球结核防治迎新诊断利器",
    "href": "http://stock.jrj.com.cn/2020/05/10174729628421.shtml",
    "datetime": "2020-05-10 17:47:23",
    "code": "300122"
  },
  {
    "title": "智飞生物1类新药宜卡正式上市",
    "href": "http://stock.jrj.com.cn/2020/05/10161229628208.shtml",
    "datetime": "2020-05-10 16:12:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：子公司获得EC药品注册批件 用于结核杆菌感染诊断",
    "href": "http://stock.jrj.com.cn/2020/04/29134529418223.shtml",
    "datetime": "2020-04-29 13:45:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：Ⅰ类新药获批 结核病筛查手段取得重大突破",
    "href": "http://stock.jrj.com.cn/2020/04/29104129416888.shtml",
    "datetime": "2020-04-29 10:41:07",
    "code": "300122"
  },
  {
    "title": "智飞生物：重组结核杆菌融合蛋白（EC）获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/04/29081929415254.shtml",
    "datetime": "2020-04-29 08:19:40",
    "code": "300122"
  },
  {
    "title": "智飞生物第一季度盈利5.16亿同比增长2.85% 全力保障产品销售",
    "href": "http://stock.jrj.com.cn/2020/04/28204529407620.shtml",
    "datetime": "2020-04-28 20:45:51",
    "code": "300122"
  },
  {
    "title": "智飞生物一季度业绩小幅增长",
    "href": "http://stock.jrj.com.cn/2020/04/28195329407119.shtml",
    "datetime": "2020-04-28 19:53:32",
    "code": "300122"
  },
  {
    "title": "智飞生物：一季度净利润5.16亿元 同比增长2.85%",
    "href": "http://stock.jrj.com.cn/2020/04/28172229406193.shtml",
    "datetime": "2020-04-28 17:22:00",
    "code": "300122"
  },
  {
    "title": "智飞生物一季度净利润同比增长2.85%",
    "href": "http://stock.jrj.com.cn/2020/04/28171229406084.shtml",
    "datetime": "2020-04-28 17:12:43",
    "code": "300122"
  },
  {
    "title": "[智飞生物]声 明",
    "href": "http://stock.jrj.com.cn/2020/04/27000030112388.shtml",
    "datetime": "2020-04-27 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物2019年报解读：“技术+市场”双驱动 核心主业高质量升级",
    "href": "http://stock.jrj.com.cn/2020/04/22144629348557.shtml",
    "datetime": "2020-04-22 14:46:06",
    "code": "300122"
  },
  {
    "title": "智飞生物：2019年净利润同比增长63.05% 拟每10派5元",
    "href": "http://stock.jrj.com.cn/2020/04/20215329331778.shtml",
    "datetime": "2020-04-20 21:53:01",
    "code": "300122"
  },
  {
    "title": "智飞生物：2019年净利同比增63% 拟10派5元",
    "href": "http://stock.jrj.com.cn/2020/04/20214729331754.shtml",
    "datetime": "2020-04-20 21:47:00",
    "code": "300122"
  },
  {
    "title": "[智飞生物]喜讯:公司喜获“江北区2019年党的建设与民主政治先进集体”称号",
    "href": "http://stock.jrj.com.cn/2020/04/11000030112386.shtml",
    "datetime": "2020-04-11 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物2020年一季度预计净利5.02亿元-5.52亿元 同比上升0%-10%",
    "href": "http://stock.jrj.com.cn/2020/04/09205129249213.shtml",
    "datetime": "2020-04-09 20:51:43",
    "code": "300122"
  },
  {
    "title": "智飞生物：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/09174029247389.shtml",
    "datetime": "2020-04-09 17:40:17",
    "code": "300122"
  },
  {
    "title": "智飞生物：股东吴冠江及一致行动人计划减持不超过1.85%公司股份",
    "href": "http://stock.jrj.com.cn/2020/04/03194229189301.shtml",
    "datetime": "2020-04-03 19:42:12",
    "code": "300122"
  },
  {
    "title": "智飞生物股东吴冠江及一致行动人拟减持股份 预计减持不超总股本1.85%",
    "href": "http://stock.jrj.com.cn/2020/04/03191529189207.shtml",
    "datetime": "2020-04-03 19:15:26",
    "code": "300122"
  },
  {
    "title": "智飞生物：股东吴冠江及一致行动人拟合计减持不超1.85%股份",
    "href": "http://stock.jrj.com.cn/2020/04/03181029188879.shtml",
    "datetime": "2020-04-03 18:10:00",
    "code": "300122"
  },
  {
    "title": "[智飞生物]安徽省科技厅、疾控中心领导一行莅临我司全资子公司智飞龙科马调研指导工作",
    "href": "http://stock.jrj.com.cn/2020/03/11000030112387.shtml",
    "datetime": "2020-03-11 00:00:00",
    "code": "300122"
  },
  {
    "title": "智飞生物一疫苗及其制备方法获发明专利",
    "href": "http://stock.jrj.com.cn/2020/03/02194828935984.shtml",
    "datetime": "2020-03-02 19:48:11",
    "code": "300122"
  },
  {
    "title": "智飞生物2019年净利23.69亿增长63.2% 疫苗产品销售稳定增长",
    "href": "http://stock.jrj.com.cn/2020/02/27210328908883.shtml",
    "datetime": "2020-02-27 21:03:55",
    "code": "300122"
  },
  {
    "title": "智飞生物2019年盈利近24亿元增逾六成",
    "href": "http://stock.jrj.com.cn/2020/02/27181628907835.shtml",
    "datetime": "2020-02-27 18:16:00",
    "code": "300122"
  },
  {
    "title": "智飞生物业绩快报：2019年净利23.69亿元 同比增长63.2%",
    "href": "http://stock.jrj.com.cn/2020/02/27172428907477.shtml",
    "datetime": "2020-02-27 17:24:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：2019年净利23.69亿元 同比增长63%",
    "href": "http://stock.jrj.com.cn/2020/02/27171128907368.shtml",
    "datetime": "2020-02-27 17:11:51",
    "code": "300122"
  },
  {
    "title": "智飞生物：已完成新冠病毒疫苗设计",
    "href": "http://stock.jrj.com.cn/2020/02/21002328865033.shtml",
    "datetime": "2020-02-21 00:23:09",
    "code": "300122"
  },
  {
    "title": "智飞生物大幅低开后直线拉升 涨近6%",
    "href": "http://stock.jrj.com.cn/2020/02/03093928751331.shtml",
    "datetime": "2020-02-03 09:39:00",
    "code": "300122"
  },
  {
    "title": "智飞生物联手中科院微生物所抗疫情 加快新型冠状病毒疫苗开发",
    "href": "http://stock.jrj.com.cn/2020/02/02205728749346.shtml",
    "datetime": "2020-02-02 20:57:00",
    "code": "300122"
  },
  {
    "title": "智飞生物携手中科院微生物所合作开发新型冠状病毒疫苗",
    "href": "http://stock.jrj.com.cn/2020/02/02204228749309.shtml",
    "datetime": "2020-02-02 20:42:45",
    "code": "300122"
  },
  {
    "title": "公告精选：智飞生物签订合作开发新型冠状病毒疫苗框架协议",
    "href": "http://stock.jrj.com.cn/2020/02/02204028749304.shtml",
    "datetime": "2020-02-02 20:40:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：签订合作开发新型冠状病毒疫苗框架协议",
    "href": "http://stock.jrj.com.cn/2020/02/02180328748881.shtml",
    "datetime": "2020-02-02 18:03:45",
    "code": "300122"
  },
  {
    "title": "智飞生物：签订合作开发新型冠状病毒疫苗框架协议",
    "href": "http://stock.jrj.com.cn/2020/02/02175728748860.shtml",
    "datetime": "2020-02-02 17:57:31",
    "code": "300122"
  },
  {
    "title": "智飞生物向湖北捐款1000万元",
    "href": "http://stock.jrj.com.cn/2020/01/27140828737671.shtml",
    "datetime": "2020-01-27 14:08:41",
    "code": "300122"
  },
  {
    "title": "智飞生物：向湖北捐款1000万元 助力疫情防控",
    "href": "http://stock.jrj.com.cn/2020/01/27130628737576.shtml",
    "datetime": "2020-01-27 13:06:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：公司在研产品暂未涉及武汉2019新型冠状病毒",
    "href": "http://stock.jrj.com.cn/2020/01/21123328712692.shtml",
    "datetime": "2020-01-21 12:33:32",
    "code": "300122"
  },
  {
    "title": "智飞生物：在研产品暂未涉及武汉2019新型冠状病毒",
    "href": "http://stock.jrj.com.cn/2020/01/21094328711536.shtml",
    "datetime": "2020-01-21 09:43:00",
    "code": "300122"
  },
  {
    "title": "多家药企披露2019年业绩预告 智飞生物预增超50% 人福医药扭亏",
    "href": "http://stock.jrj.com.cn/2020/01/13195628668951.shtml",
    "datetime": "2020-01-13 19:56:24",
    "code": "300122"
  },
  {
    "title": "智飞生物股价创历史新高控股股东是否会继续减持？",
    "href": "http://stock.jrj.com.cn/2020/01/08073928649891.shtml",
    "datetime": "2020-01-08 07:39:00",
    "code": "300122"
  },
  {
    "title": "智飞生物2019年利润22.5亿元至25.4亿元 同比增长55%-75%",
    "href": "http://stock.jrj.com.cn/2020/01/03224328626626.shtml",
    "datetime": "2020-01-03 22:43:41",
    "code": "300122"
  },
  {
    "title": "智飞生物：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/03213028626412.shtml",
    "datetime": "2020-01-03 21:30:00",
    "code": "300122"
  },
  {
    "title": "智飞生物2019年净利预增55%-75%",
    "href": "http://stock.jrj.com.cn/2020/01/03212328626395.shtml",
    "datetime": "2020-01-03 21:23:30",
    "code": "300122"
  },
  {
    "title": "智飞生物：2019年度净利预增55%-75%",
    "href": "http://stock.jrj.com.cn/2020/01/03200928626181.shtml",
    "datetime": "2020-01-03 20:09:05",
    "code": "300122"
  },
  {
    "title": "智飞生物：2019年净利预增55%-75%",
    "href": "http://stock.jrj.com.cn/2020/01/03194528626115.shtml",
    "datetime": "2020-01-03 19:45:00",
    "code": "300122"
  },
  {
    "title": "智飞生物冻干重组结核疫苗Ⅰa期临床试验结果良好",
    "href": "http://stock.jrj.com.cn/2019/12/26222328592899.shtml",
    "datetime": "2019-12-26 22:23:50",
    "code": "300122"
  },
  {
    "title": "智飞生物：收到冻干重组结核疫苗Ⅰa期临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2019/12/26182328591378.shtml",
    "datetime": "2019-12-26 18:23:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：冻干重组结核疫苗将开展下一步临床试验",
    "href": "http://stock.jrj.com.cn/2019/12/26182028591348.shtml",
    "datetime": "2019-12-26 18:20:43",
    "code": "300122"
  },
  {
    "title": "智飞生物实控人减持1680万股为“减压”",
    "href": "http://stock.jrj.com.cn/2019/12/10040528511124.shtml",
    "datetime": "2019-12-10 04:05:40",
    "code": "300122"
  },
  {
    "title": "智飞生物实控人转让1.05%股份引入战略投资者",
    "href": "http://stock.jrj.com.cn/2019/12/09222428510672.shtml",
    "datetime": "2019-12-09 22:24:06",
    "code": "300122"
  },
  {
    "title": "智飞生物现四笔大宗交易 折价约10%成交额近7亿元",
    "href": "http://stock.jrj.com.cn/2019/12/09190228509953.shtml",
    "datetime": "2019-12-09 19:02:00",
    "code": "300122"
  },
  {
    "title": "智飞生物业绩大涨难掩成本激增 5亿元增资全资子公司",
    "href": "http://stock.jrj.com.cn/2019/10/23084428286709.shtml",
    "datetime": "2019-10-23 08:44:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：前三季度净利17.63亿元 同比增长62%",
    "href": "http://stock.jrj.com.cn/2019/10/21220828278914.shtml",
    "datetime": "2019-10-21 22:08:30",
    "code": "300122"
  },
  {
    "title": "智飞生物前三季度净利增逾六成",
    "href": "http://stock.jrj.com.cn/2019/10/21215228279036.shtml",
    "datetime": "2019-10-21 21:52:42",
    "code": "300122"
  },
  {
    "title": "智飞生物：前三季度净利17.63亿元 同比增62%",
    "href": "http://stock.jrj.com.cn/2019/10/21201928278572.shtml",
    "datetime": "2019-10-21 20:19:00",
    "code": "300122"
  },
  {
    "title": "智飞生物：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/08230028215329.shtml",
    "datetime": "2019-10-08 23:00:02",
    "code": "300122"
  },
  {
    "title": "业绩汇总：智飞生物前三季业绩预增52％-72％",
    "href": "http://stock.jrj.com.cn/2019/10/08212728215189.shtml",
    "datetime": "2019-10-08 21:27:20",
    "code": "300122"
  },
  {
    "title": "智飞生物：前三季净利同比预增52%-72%",
    "href": "http://stock.jrj.com.cn/2019/10/08202428215053.shtml",
    "datetime": "2019-10-08 20:24:57",
    "code": "300122"
  },
  {
    "title": "智飞生物：前三季净利预增52%-72%",
    "href": "http://stock.jrj.com.cn/2019/10/08195128215007.shtml",
    "datetime": "2019-10-08 19:51:15",
    "code": "300122"
  },
  {
    "title": "智飞生物定增获证监会核准批文",
    "href": "http://stock.jrj.com.cn/2019/09/18210028149972.shtml",
    "datetime": "2019-09-18 21:00:38",
    "code": "300122"
  },
  {
    "title": "智飞生物：非公开发行股票申请获核准",
    "href": "http://stock.jrj.com.cn/2019/09/18192128149672.shtml",
    "datetime": "2019-09-18 19:21:00",
    "code": "300122"
  },
  {
    "title": "【智飞生物】大幅拉升2.95% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06140728100323.shtml",
    "datetime": "2019-09-06 14:07:14",
    "code": "300122"
  },
  {
    "title": "【智飞生物】大幅拉升3.11% 股价创历史新高",
    "href": "http://stock.jrj.com.cn/2019/09/06110128099265.shtml",
    "datetime": "2019-09-06 11:01:02",
    "code": "300122"
  },
  {
    "title": "智飞生物获两项发明专利证书",
    "href": "http://stock.jrj.com.cn/2019/09/05203128096066.shtml",
    "datetime": "2019-09-05 20:31:45",
    "code": "300122"
  },
  {
    "title": "智飞生物：组份百白破疫苗获得国家药品监督管理局药品临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/09/01172728072080.shtml",
    "datetime": "2019-09-01 17:27:30",
    "code": "300122"
  },
  {
    "title": "智飞生物董事长蒋仁生获全国非公经济人士优秀建设者称号",
    "href": "http://stock.jrj.com.cn/2019/08/30183828063702.shtml",
    "datetime": "2019-08-30 18:38:00",
    "code": "300122"
  },
  {
    "title": "九价HPV疫苗业务暴增195倍 智飞生物2019中报营收接近去年全年",
    "href": "http://stock.jrj.com.cn/2019/08/30092628060381.shtml",
    "datetime": "2019-08-30 09:26:00",
    "code": "300122"
  },
  {
    "title": "智飞生物上半年盈利增长68% 疫苗批签发合格率100%",
    "href": "http://stock.jrj.com.cn/2019/08/29213128057936.shtml",
    "datetime": "2019-08-29 21:31:24",
    "code": "300122"
  },
  {
    "title": "智飞生物2019年上半年净利11.47亿 本期销售代理进口产品增加",
    "href": "http://stock.jrj.com.cn/2019/08/29203428057616.shtml",
    "datetime": "2019-08-29 20:34:12",
    "code": "300122"
  },
  {
    "title": "智飞生物：上半年净利11.47亿元 同比增长68%",
    "href": "http://stock.jrj.com.cn/2019/08/29171028056290.shtml",
    "datetime": "2019-08-29 17:10:03",
    "code": "300122"
  },
  {
    "title": "智飞生物员工持股计划完成股票购买",
    "href": "http://stock.jrj.com.cn/2019/07/30211727905413.shtml",
    "datetime": "2019-07-30 21:17:28",
    "code": "300122"
  },
  {
    "title": "智飞生物实控人让利员工持股计划 800名员工斥资6.6亿元认购1600万股",
    "href": "http://stock.jrj.com.cn/2019/07/22213327872256.shtml",
    "datetime": "2019-07-22 21:33:00",
    "code": "300122"
  }
]